We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




System Offers Both Morphology Preservation and Biomolecule Stabilization

By LabMedica International staff writers
Posted on 02 Feb 2009
An integrated laboratory system for sample fixation, stabilization, and purification is available. More...
The system allows scientists to perform histology, immunohistochemistry, and stabilized nucleic acid extractions from one sample without compromising workflow.

The system has two components: a tissue container and tissue kits. The dual-chambered container is prefilled with two reagents: a tissue fixative for fast penetration and fixation, and a tissue stabilizer for storage and transport. The fixation process uses a standard histocasette with a fixative that is an alternative to formalin and is stopped when the sample is transferred into the stabilizer. Fixation time is standardized at two to four hours.

The sample remains stable in the tissue stabilizer for transport and storage prior to processing. The tissue can then be paraffin embedded and processed in pathology workflows. After the tissue sample has been stabilized in tissue containers (and optionally paraffin embedded), ribonucleic acid (RNA), micro (mi)RNA, and DNA can be purified using tissue kits.

Laboratories working with human and animal tissue need to conduct a variety of analyses on limited sample materials. The recognized standard for preserving tissue morphology is formalin fixation/paraffin embedding (FFPE). This method provides excellent results for morphological studies, but it does not preserve biomolecules. As a result, the DNA, RNA, and miRNA molecules degrade, preventing the complete analysis required. This would hinder applications such as the development of diagnostics and therapeutics, biomarker discovery, and case-controlled and population-based clinical studies.

The technology, called the PAXgene tissue system, is the newest addition to Qiagen's (Frankfurt, Germany) suite of tissue management technologies. The suite includes integrated products that standardize all steps of the workflow, starting with archived or prospectively collected tissues and ending with data analysis. This ensures comparability and reproducibility of data from laboratory to laboratory.

Qiagen is a global provider of sample and assay technologies. Sample technologies are used to isolate and process nucleic acids and proteins from biologic samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutic, and biotechnology companies.

Related Links:

Qiagen




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.